|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
- Q# i3 a5 g; ]5 `was to close its brain research facility in Basel, Switzerland,
z3 l) P9 S; G6 k5 othe story noted that this move closely followed similar cuts3 U) r! i# Z% \. `3 H
by rival pharmaceutical firms. As a report from the European College
: G0 b3 p$ q$ ?# m, j0 A, mof Neuropsychopharmacology6 c) X+ f. B0 @' s, S3 r0 |
had warned a few months earlier, the
$ x! m9 l! w: `5 y2 R$ ~' Fabandonment of research into new psychiatric drugs by AstraZeneca,
$ Q# R: z4 D: M$ N6 W r0 { d- {GlaxoSmithKline
7 o* Z; D- {# m( w9 Q6 z, T ^and others meant that “withdrawal of research
0 s: Y; E. J# Mresources is a withdrawal of hope for patients and their families”.( N$ R' z6 [6 D8 B4 x" L: V
6 ~5 o2 y7 P, B$ X. K% C
" m' J7 m& c2 l% [; Y回复有免费下载链接8 }3 I/ M$ d2 _" d( q4 j
, t& a* J) g) R, W/ g3 }2 o( e |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
